Prosecution Insights
Last updated: October 02, 2026
Application No. 18/717,322

BLOOD FLOW RESTRICTIVE CUFF WITH INTEGRATED BLOOD FLOW SENSOR

Non-Final OA §103§112
Filed
Jun 06, 2024
Priority
Dec 17, 2021 — provisional 63/291,260 +1 more
Examiner
BERHANU, ETSUB D
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Kci Manufacturing Unlimited Company
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
1y 2m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
528 granted / 809 resolved
-4.7% vs TC avg
Strong +25% interview lift
Without
With
+24.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
46 currently pending
Career history
851
Total Applications
across all art units

Statute-Specific Performance

§101
19.0%
-21.0% vs TC avg
§103
31.5%
-8.5% vs TC avg
§102
10.4%
-29.6% vs TC avg
§112
32.4%
-7.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 809 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-10, in the reply filed on 04 August 2026 is acknowledged. Information Disclosure Statement The 21-page information disclosure statement (IDS) submitted on 06 June 2024 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. References that were lined through were not considered as no copies of the references were provided. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 8 is drawn to a device, but recites a method step. This renders the claim indefinite. It is unclear what further limitation claim 8 provides to the claimed invention by reciting that the source of positive pressure is adjusted manually. For this examination, the claim is being interpreted such that the source of positive pressure is configured to be or capable of being adjusted manually. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-10 are rejected under 35 U.S.C. 103 as being unpatentable over Chen et al.’082 (US Pub No. 2012/0215082) in view of Shin et al.’041 (US Pub No. 2006/0253041). Regarding claim 1, Figure 2 of Chen et al.’082 discloses a cuff 18 for measuring arterial blood pressure (section [0030]), the cuff comprising: an interior surface configured to be secured around the limb (sections [0018], [0020]; and see interior surface 22 of Figure 1); a bladder configured to be fluidly coupled to a source of positive pressure (sections [0020], [0026]: inflatable cuff 18 is a bladder, and it is connected via inflation line 20 to a source of positive pressure), and adapted to inflate in response to application of a positive pressure and restrict blood flow through the arteries of the limb when inflated (sections [0028], [0032]); and a blood flow sensor coupled to the interior surface and disposed between the interior surface and the limb (see Figures 1, 5, 6, and 7 - sensor 14), the blood flow sensor configured to monitor blood flow through the arteries of the limb (sections [0019], [0032-0033]). Chen et al.’082 discloses all of the elements of the current invention, as discussed above, except for the blood flow sensor being configured to measure blood flow through the arteries of the limb. Shin et al.’041 teaches using measurements from a blood flow sensor within a blood pressure cuff to improve the signal to noise ratio of a signal measured by a blood pressure sensor (section [0045]). It would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the cuff of Chen et al.’082 such that its blood flow sensor also measures blood flow through the arteries of the limb, as Shin et al.’041 teaches that the blood flow measurements could be used to improve the signal to noise ratio of the blood pressure sensor of Chen et al.’082 (Chen et al.’082 includes a blood pressure sensor for measuring blood pressure (sections [0026], [0030])). Regarding claim 2, Chen et al.’082 discloses that the blood flow sensor is a PPG sensor having an LED and a photodiode (sections [0019], [0021]). Regarding claim 3, Chen et al.’082 discloses that the PPG sensor operates in an absorptive mode (section [0019]). Official notice is being taken that for the PPG sensor to operate in an absorptive mode, the LED and photodiode would need to be disposed on opposite sides of the interior surface of the cuff. Regarding claim 4, Chen et al.’082 discloses that the PPG sensor operates in a reflectance mode (section [0019]). Official notice is being taken that for the PPG sensor to operate in a reflectance mode, the LED and photodiode would need to be aligned on one side of the interior surface of the cuff. Regarding claim 5, Chen et al.’082 discloses that the PPG sensor is configured to measure an oxygen level of blood in the limb (section [0020]). Regarding claim 6, Chen et al.’082 discloses that the blood flow sensor is an optical sensor having an LED and a photodiode (sections [0019], [0021]). Regarding claim 7, Chen et al.’082 discloses that the optical sensor operates in a reflectance mode (section [0019]). Official notice is being taken that for the PPG sensor to operate in a reflectance mode, the LED and photodiode would need to be aligned on one side of the interior surface of the cuff. Regarding claim 8, Chen et al.’082 discloses that the source of positive pressure can be adjusted manually (section [0020]). Regarding claim 9, Chen et al.’082 discloses that the blood flow sensor is communicatively coupled to a controller, the controller being configured to receive signals from the blood flow sensor (section [0025]: controller 26). Regarding claim 10, Chen et al.’082 discloses that the controller is communicatively coupled to the source of positive pressure and adjusts the source of positive pressure in response to the signals received from the blood flow sensor (sections [0026], [0033], [0035]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. LaPlante et al.’059 (US Pub No. 2008/0183059 – cited by Applicant) discloses a cuff for measuring blood flow through arteries of a limb, the cuff comprising each of the elements recited in claim 1 (see Figure 1). Su et al.’690 (US Pub No. 2015/0257690) teaches a controller communicatively coupled to a source of positive pressure, wherein the controller is configured to adjust a source of positive pressure in response to signals received from a blood flow sensor. The controller is configured to adjust the source of positive pressure in response to the blood flow sensor signals in order to trigger cuff measurements via a blood pressure sensor within the cuff at appropriate times (section [0047]). Each of the following references provides evidence that it is well known in the art to use a PPG sensor to measure blood flow: LaPlante et al.’059 (sections [0036], [0040]); Knickerbocker et al.’153 (US Pub No. 2018/0078153 – section [0025]); Khachaturian et al.’478 (US Pub No. 2018/0235478 – section [0093]); Freeman et al.’147 (US Pub No. 2018/0272147 – section [0081]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to ETSUB D BERHANU whose telephone number is (571)270-5410. The examiner can normally be reached Mon-Fri 9:00am-5:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ETSUB D BERHANU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Jun 06, 2024
Application Filed
Sep 04, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741148
Methods and Systems for Treating Neurological Movement Disorders
8y 10m to grant Granted Sep 22, 2026
Patent 12708285
OXYGEN MASK RESPIROMETER
3y 11m to grant Granted Aug 18, 2026
Patent 12702325
SKIN FLAP THICKNESS ESTIMATION
3y 4m to grant Granted Aug 11, 2026
Patent 12697058
SYSTEMS AND METHODS FOR SEIZURE DETECTION BASED ON CHANGES IN ELECTROENCEPHALOGRAM (EEG) NON-LINEARITIES
2y 2m to grant Granted Aug 04, 2026
Patent 12690820
DETECTION OF PROLONGED POSTPRANDIAL HYPERGLYCEMIA, GLYCEMIC PEAK LINEAR PREDICTION AND INSULIN DELIVERY ADJUSTMENT
2y 9m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
90%
With Interview (+24.8%)
3y 6m (~1y 2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 809 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month